Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
34
AVNS Quote, Financials, Valuation and Earnings
Last price:
$11.26
Seasonality move
:
-2.76%
Day range:
$11.05 - $11.38
52-week range:
$9.30 - $19.00
Dividend yield:
0%
P/E ratio:
45.94x
P/S ratio:
0.75x
P/B ratio:
0.67x
Volume:
428.6K
Avg. volume:
530.1K
1-year change:
-40.39%
Market cap:
$522.7M
Revenue:
$687.8M
EPS (TTM):
-$10.19
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
AVNS
Avanos Medical, Inc.
|
$164.5M | $0.12 | -2.73% | 30.01% | $14.00 |
|
BSX
Boston Scientific Corp.
|
$5B | $0.71 | 15.72% | 105.56% | $126.48 |
|
IVF
INVO Fertility, Inc.
|
$1.8M | -- | -8.8% | -- | -- |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$2.5M | -- | -57.12% | -57.14% | $2.23 |
|
NTRB
Nutriband, Inc.
|
$675K | -$0.17 | 4.52% | -54.85% | $15.00 |
|
SINT
SINTX Technologies, Inc.
|
$400K | -$0.46 | -74.97% | -92.1% | $16.75 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
AVNS
Avanos Medical, Inc.
|
$11.26 | $14.00 | $522.7M | 45.94x | $0.00 | 0% | 0.75x |
|
BSX
Boston Scientific Corp.
|
$97.52 | $126.48 | $144.6B | 52.16x | $0.00 | 0% | 7.52x |
|
IVF
INVO Fertility, Inc.
|
$1.54 | -- | $23.3M | -- | $0.00 | 0% | 0.03x |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$0.71 | $2.23 | $35.6M | -- | $0.00 | 0% | 2.60x |
|
NTRB
Nutriband, Inc.
|
$4.82 | $15.00 | $57.9M | -- | $0.00 | 0% | 20.81x |
|
SINT
SINTX Technologies, Inc.
|
$4.03 | $16.75 | $15.5M | -- | $0.00 | 0% | 6.83x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
AVNS
Avanos Medical, Inc.
|
14.67% | 1.071 | 24.92% | 1.26x |
|
BSX
Boston Scientific Corp.
|
33.99% | 0.345 | 8.31% | 0.81x |
|
IVF
INVO Fertility, Inc.
|
41.99% | -0.446 | 10.12% | 0.07x |
|
NMTC
NeuroOne Medical Technologies Corp.
|
3.49% | 2.039 | 0.87% | 5.64x |
|
NTRB
Nutriband, Inc.
|
3.08% | 2.796 | 0.31% | 4.55x |
|
SINT
SINTX Technologies, Inc.
|
45.47% | 1.079 | 22.94% | 1.47x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
AVNS
Avanos Medical, Inc.
|
$81.1M | $13.1M | -44.75% | -52.63% | 7.37% | $7M |
|
BSX
Boston Scientific Corp.
|
$3.3B | $1B | 8.19% | 12.46% | 20.55% | $1.2B |
|
IVF
INVO Fertility, Inc.
|
$492.6K | -$1.6M | -188.23% | -471.28% | -93.08% | -$1.8M |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$914.8K | -$1.9M | -151.86% | -166.02% | -111.24% | -$1.5M |
|
NTRB
Nutriband, Inc.
|
$156.9K | -$2M | -114.42% | -117.44% | -321.8% | -$1.3M |
|
SINT
SINTX Technologies, Inc.
|
-$66K | -$3.4M | -115.95% | -208.36% | -1612.98% | -$2.6M |
Avanos Medical, Inc. vs. Competitors
-
Which has Higher Returns AVNS or BSX?
Boston Scientific Corp. has a net margin of -0.79% compared to Avanos Medical, Inc.'s net margin of 14.91%. Avanos Medical, Inc.'s return on equity of -52.63% beat Boston Scientific Corp.'s return on equity of 12.46%.
Company Gross Margin Earnings Per Share Invested Capital AVNSAvanos Medical, Inc.45.61% -$0.03 $911.7M BSXBoston Scientific Corp.65.31% $0.50 $35.7B -
What do Analysts Say About AVNS or BSX?
Avanos Medical, Inc. has a consensus price target of $14.00, signalling upside risk potential of 24.33%. On the other hand Boston Scientific Corp. has an analysts' consensus of $126.48 which suggests that it could grow by 29.7%. Given that Boston Scientific Corp. has higher upside potential than Avanos Medical, Inc., analysts believe Boston Scientific Corp. is more attractive than Avanos Medical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AVNSAvanos Medical, Inc.0 1 0 BSXBoston Scientific Corp.25 2 0 -
Is AVNS or BSX More Risky?
Avanos Medical, Inc. has a beta of 1.095, which suggesting that the stock is 9.451% more volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.673, suggesting its less volatile than the S&P 500 by 32.691%.
-
Which is a Better Dividend Stock AVNS or BSX?
Avanos Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avanos Medical, Inc. pays -- of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVNS or BSX?
Avanos Medical, Inc. quarterly revenues are $177.8M, which are smaller than Boston Scientific Corp. quarterly revenues of $5.1B. Avanos Medical, Inc.'s net income of -$1.4M is lower than Boston Scientific Corp.'s net income of $755M. Notably, Avanos Medical, Inc.'s price-to-earnings ratio is 45.94x while Boston Scientific Corp.'s PE ratio is 52.16x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avanos Medical, Inc. is 0.75x versus 7.52x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVNSAvanos Medical, Inc.0.75x 45.94x $177.8M -$1.4M BSXBoston Scientific Corp.7.52x 52.16x $5.1B $755M
-
Which has Higher Returns AVNS or IVF?
INVO Fertility, Inc. has a net margin of -0.79% compared to Avanos Medical, Inc.'s net margin of -150.51%. Avanos Medical, Inc.'s return on equity of -52.63% beat INVO Fertility, Inc.'s return on equity of -471.28%.
Company Gross Margin Earnings Per Share Invested Capital AVNSAvanos Medical, Inc.45.61% -$0.03 $911.7M IVFINVO Fertility, Inc.28.04% -$6.14 $10.1M -
What do Analysts Say About AVNS or IVF?
Avanos Medical, Inc. has a consensus price target of $14.00, signalling upside risk potential of 24.33%. On the other hand INVO Fertility, Inc. has an analysts' consensus of -- which suggests that it could grow by 9250.65%. Given that INVO Fertility, Inc. has higher upside potential than Avanos Medical, Inc., analysts believe INVO Fertility, Inc. is more attractive than Avanos Medical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AVNSAvanos Medical, Inc.0 1 0 IVFINVO Fertility, Inc.0 0 0 -
Is AVNS or IVF More Risky?
Avanos Medical, Inc. has a beta of 1.095, which suggesting that the stock is 9.451% more volatile than S&P 500. In comparison INVO Fertility, Inc. has a beta of 2.540, suggesting its more volatile than the S&P 500 by 153.97%.
-
Which is a Better Dividend Stock AVNS or IVF?
Avanos Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. INVO Fertility, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avanos Medical, Inc. pays -- of its earnings as a dividend. INVO Fertility, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVNS or IVF?
Avanos Medical, Inc. quarterly revenues are $177.8M, which are larger than INVO Fertility, Inc. quarterly revenues of $1.8M. Avanos Medical, Inc.'s net income of -$1.4M is higher than INVO Fertility, Inc.'s net income of -$2.6M. Notably, Avanos Medical, Inc.'s price-to-earnings ratio is 45.94x while INVO Fertility, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avanos Medical, Inc. is 0.75x versus 0.03x for INVO Fertility, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVNSAvanos Medical, Inc.0.75x 45.94x $177.8M -$1.4M IVFINVO Fertility, Inc.0.03x -- $1.8M -$2.6M
-
Which has Higher Returns AVNS or NMTC?
NeuroOne Medical Technologies Corp. has a net margin of -0.79% compared to Avanos Medical, Inc.'s net margin of -88.5%. Avanos Medical, Inc.'s return on equity of -52.63% beat NeuroOne Medical Technologies Corp.'s return on equity of -166.02%.
Company Gross Margin Earnings Per Share Invested Capital AVNSAvanos Medical, Inc.45.61% -$0.03 $911.7M NMTCNeuroOne Medical Technologies Corp.53.94% -$0.03 $8.5M -
What do Analysts Say About AVNS or NMTC?
Avanos Medical, Inc. has a consensus price target of $14.00, signalling upside risk potential of 24.33%. On the other hand NeuroOne Medical Technologies Corp. has an analysts' consensus of $2.23 which suggests that it could grow by 212.5%. Given that NeuroOne Medical Technologies Corp. has higher upside potential than Avanos Medical, Inc., analysts believe NeuroOne Medical Technologies Corp. is more attractive than Avanos Medical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AVNSAvanos Medical, Inc.0 1 0 NMTCNeuroOne Medical Technologies Corp.1 0 0 -
Is AVNS or NMTC More Risky?
Avanos Medical, Inc. has a beta of 1.095, which suggesting that the stock is 9.451% more volatile than S&P 500. In comparison NeuroOne Medical Technologies Corp. has a beta of 0.703, suggesting its less volatile than the S&P 500 by 29.673%.
-
Which is a Better Dividend Stock AVNS or NMTC?
Avanos Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avanos Medical, Inc. pays -- of its earnings as a dividend. NeuroOne Medical Technologies Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVNS or NMTC?
Avanos Medical, Inc. quarterly revenues are $177.8M, which are larger than NeuroOne Medical Technologies Corp. quarterly revenues of $1.7M. Avanos Medical, Inc.'s net income of -$1.4M is higher than NeuroOne Medical Technologies Corp.'s net income of -$1.5M. Notably, Avanos Medical, Inc.'s price-to-earnings ratio is 45.94x while NeuroOne Medical Technologies Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avanos Medical, Inc. is 0.75x versus 2.60x for NeuroOne Medical Technologies Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVNSAvanos Medical, Inc.0.75x 45.94x $177.8M -$1.4M NMTCNeuroOne Medical Technologies Corp.2.60x -- $1.7M -$1.5M
-
Which has Higher Returns AVNS or NTRB?
Nutriband, Inc. has a net margin of -0.79% compared to Avanos Medical, Inc.'s net margin of -321.33%. Avanos Medical, Inc.'s return on equity of -52.63% beat Nutriband, Inc.'s return on equity of -117.44%.
Company Gross Margin Earnings Per Share Invested Capital AVNSAvanos Medical, Inc.45.61% -$0.03 $911.7M NTRBNutriband, Inc.25.21% -$2.12 $8.8M -
What do Analysts Say About AVNS or NTRB?
Avanos Medical, Inc. has a consensus price target of $14.00, signalling upside risk potential of 24.33%. On the other hand Nutriband, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 211.2%. Given that Nutriband, Inc. has higher upside potential than Avanos Medical, Inc., analysts believe Nutriband, Inc. is more attractive than Avanos Medical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AVNSAvanos Medical, Inc.0 1 0 NTRBNutriband, Inc.1 0 0 -
Is AVNS or NTRB More Risky?
Avanos Medical, Inc. has a beta of 1.095, which suggesting that the stock is 9.451% more volatile than S&P 500. In comparison Nutriband, Inc. has a beta of 1.907, suggesting its more volatile than the S&P 500 by 90.735%.
-
Which is a Better Dividend Stock AVNS or NTRB?
Avanos Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avanos Medical, Inc. pays -- of its earnings as a dividend. Nutriband, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVNS or NTRB?
Avanos Medical, Inc. quarterly revenues are $177.8M, which are larger than Nutriband, Inc. quarterly revenues of $622.5K. Avanos Medical, Inc.'s net income of -$1.4M is higher than Nutriband, Inc.'s net income of -$2M. Notably, Avanos Medical, Inc.'s price-to-earnings ratio is 45.94x while Nutriband, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avanos Medical, Inc. is 0.75x versus 20.81x for Nutriband, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVNSAvanos Medical, Inc.0.75x 45.94x $177.8M -$1.4M NTRBNutriband, Inc.20.81x -- $622.5K -$2M
-
Which has Higher Returns AVNS or SINT?
SINTX Technologies, Inc. has a net margin of -0.79% compared to Avanos Medical, Inc.'s net margin of -1701.44%. Avanos Medical, Inc.'s return on equity of -52.63% beat SINTX Technologies, Inc.'s return on equity of -208.36%.
Company Gross Margin Earnings Per Share Invested Capital AVNSAvanos Medical, Inc.45.61% -$0.03 $911.7M SINTSINTX Technologies, Inc.-31.73% -$3.46 $7.5M -
What do Analysts Say About AVNS or SINT?
Avanos Medical, Inc. has a consensus price target of $14.00, signalling upside risk potential of 24.33%. On the other hand SINTX Technologies, Inc. has an analysts' consensus of $16.75 which suggests that it could grow by 315.63%. Given that SINTX Technologies, Inc. has higher upside potential than Avanos Medical, Inc., analysts believe SINTX Technologies, Inc. is more attractive than Avanos Medical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AVNSAvanos Medical, Inc.0 1 0 SINTSINTX Technologies, Inc.2 0 0 -
Is AVNS or SINT More Risky?
Avanos Medical, Inc. has a beta of 1.095, which suggesting that the stock is 9.451% more volatile than S&P 500. In comparison SINTX Technologies, Inc. has a beta of 0.633, suggesting its less volatile than the S&P 500 by 36.717%.
-
Which is a Better Dividend Stock AVNS or SINT?
Avanos Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SINTX Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avanos Medical, Inc. pays -- of its earnings as a dividend. SINTX Technologies, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVNS or SINT?
Avanos Medical, Inc. quarterly revenues are $177.8M, which are larger than SINTX Technologies, Inc. quarterly revenues of $208K. Avanos Medical, Inc.'s net income of -$1.4M is higher than SINTX Technologies, Inc.'s net income of -$3.5M. Notably, Avanos Medical, Inc.'s price-to-earnings ratio is 45.94x while SINTX Technologies, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avanos Medical, Inc. is 0.75x versus 6.83x for SINTX Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVNSAvanos Medical, Inc.0.75x 45.94x $177.8M -$1.4M SINTSINTX Technologies, Inc.6.83x -- $208K -$3.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
